Now Britain’s genome-busters use Covid success to target superbugs

  22 March 2021

Britain’s world-leading coronavirus sequencing infrastructure can be repurposed to help to tackle the “silent pandemic” of antibiotic resistance, scientists have said, as the government predicted superbugs could cause 20 million deaths a year worldwide by 2050.

Last week the integrated review of security and foreign policy identified the evolution of drug-resistant microbes as a critical strategic threat alongside the rise of China and Russia.

Further reading: The Times
Author(s): Tom Whipple
Smart Innovations  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University

Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!